Ireland· IE-PA-PA23355/020/001
TEVETEN 400 mg, film-coated tablets
A eprosartan product containing eprosartan, registered in Ireland by Viatris Healthcare Limited. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Eprosartan is registered in 8 of 19 countries.
Countries holding a registration under ATC C09CA02 (eprosartan), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 4 of them publish a price we can compare per daily dose
Eprosartan · ATC C09CA02
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- United Kingdom
Price per daily dose
What a daily dose of eprosartan costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eprosartan · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- ES Spain$0.58
The record
At a glance
HPRA (Ireland)- Active substance
- Eprosartan
- Manufacturer
- Viatris Healthcare Limited
- Country
- Ireland (IE)
- ATC code
- C09CA02
- ATC class
- Eprosartan
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23355/020/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
201 interactions on record for eprosartan.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eprosartan · interactions on record
201 records
- 7 severe
- 113 moderate
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eprosartan in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTevetenAbbott Oy
- NetherlandsTeveten 400, filmomhulde tabletten 400 mgViatris Healthcare B.V.
- United KingdomEprosartan 300mg tabletsAmarox Ltd
- SpainEPROSARTAN MYLAN PHARMACEUTICALS 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGMylan Pharmaceuticals S.L.
- BelgiumTeveten 300 mgViatris
- GermanyEprosartan AmaroxAmarox Pharma Gmbh
- NorwayTeveten2care4 ApS
- SwedenTeveten 600 mg Filmdragerad tablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Teveten
- Belgium · Teveten
- Bulgaria · Теветен
- Germany · Eprosartan Amarox, Eprosartan Ratiopharm
- Spain · Futuran, Navixen
- Finland · Teveten
- United Kingdom (Northern Ireland) · Eprosartan Activase Pharmaceuticals, Eprosartan Amarox
- Greece · Teveten
- Luxembourg · Teveten
- Netherlands · Teveten
- Norway · Teveten
- Portugal · Teveten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a4c3e3e-fe3f-4632-be28-abb9607a3487 GET /v1/drugs/2a4c3e3e-fe3f-4632-be28-abb9607a3487?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C09CA",
"C09CA02"
],
"strength": null,
"pa_number": "PA23355/020/001",
"substances": [
"Eprosartan"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "05/09/1997",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about eprosartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.